Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Disease Progression × Etoposide × 30 days × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 12 Lymphoma, Large B-Cell, Diffuse 6 Lung Neoplasms 5 Burkitt Lymphoma 5 Recurrence 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Hodgkin Disease 4 Sarcoma, Ewing 3 Neoplasms 3 Lymphoma 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Teratoma 2 Sarcoma 2 Rhabdoid Tumor 2 Neuroendocrine Tumors 2 Neoplasms, Germ Cell and Embryonal 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Ependymoma 2 Carcinoma, Embryonal 2 Waldenstrom Macroglobulinemia 1 Vasculitis, Central Nervous System 1 Urologic Neoplasms 1 Thyroid Neoplasms 1 Stiff-Person Syndrome 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Small Cell Lung Cancer Extensive Stage 1

Interventions

niraparib 1 fludarabine phosphate 1 fludarabine 1 copanlisib 1 capivasertib 1 axicabtagene ciloleucel 1 Receptors, Interleukin-6 1 Interleukin 1 Receptor Antagonist Protein 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡